Page last updated: 2024-12-07

gamma-glutamylglutamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Gamma-glutamylglutamate (gamma-Glu-Glu) is a dipeptide composed of two glutamate residues linked by a gamma-peptide bond. It is a naturally occurring compound found in various tissues and biological fluids, including the brain, liver, and blood. Gamma-Glu-Glu is synthesized through the enzymatic activity of gamma-glutamyltransferase (GGT), an enzyme involved in the metabolism of glutathione, a major antioxidant. This dipeptide has been shown to exhibit various biological effects, including neuroprotective activity, antioxidant properties, and regulation of glutamate signaling. It has been proposed to play a role in the pathogenesis of various diseases, such as Alzheimer's disease, Parkinson's disease, and cancer. The study of gamma-Glu-Glu focuses on understanding its biological functions, its potential therapeutic applications, and its involvement in disease development.'

gamma-glutamylglutamate: an endogenous dipeptide in the rat olfactory bulb which activates N-methyl-D-aspartate receptors; RN given refers to (L)-isomer; RN for cpd without isomeric designation not avail 9/93 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92865
CHEBI ID73705
SCHEMBL ID236257
MeSH IDM0220515

Synonyms (40)

Synonym
(5-l-glutamyl)-l-glutamate
C05282
gamma-glutamylglutamate
1116-22-9
CHEBI:73705
gamma-l-glu-l-glu
unii-6018kcn7x2
n-gamma-l-glutamyl-l-glutamic acid
einecs 214-233-2
6018kcn7x2 ,
AKOS016014286
g-glu-glu
SCHEMBL236257
gamma-l-glutamyl-l-glutamic acid
gamma-glutamylglutamic acid
h-gamma-glu-glu-oh
l-glutamic acid, n-l-.gamma.-glutamyl-
n-(4-amino-4-carboxybutanoyl)glutamic acid #
.gamma.-l-glutamyl-l-glutamic acid
(s)-2-((s)-4-amino-4-carboxybutanamido)pentanedioic acid
(2s)-2-[(4s)-4-amino-4-carboxybutanamido]pentanedioic acid
gamma glutamylglutamic acid
glutamic acid, n-l-.gamma.-glutamyl-, l-
5-glutamyl glutamate
l-.gamma.-glutamyl-l-glutamic acid
l-glutamic acid, l-.gamma.-glutamyl-
.gamma.-glutamylglutamic acid
h-glu(glu-oh)-oh
mfcd00002630
n-(4-amino-4-carboxy-1-hydroxybutylidene)glutamic acid
DTXSID20912237
(2~{s})-2-[[(4~{s})-4-azanyl-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]pentanedioic acid
KSN ,
Q27143983
(2s)-2-[[(4s)-4-amino-4-carboxybutanoyl]amino]pentanedioic acid
l--glutamyl-l-glutamic acid
AS-76975
CS-0065178
HY-118090
l-|a-glutamyl-l-glutamic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dipeptideAny molecule that contains two amino-acid residues connected by peptide linkages.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]